Cytokine mediated gene therapy involves tumor-selective gene transfer and in situ expression of various cytokine genes such as IL2, IL4, IL12, and IFNβ/γ which can induce robust immune responses to glioma cells (Iwami et al., 2010; Tobias et al., 2013). This evidence concerns the gene IL2 and central nervous system cancer.